Colon Cancer Diagnostic Tests Market, by Test (FECAL OCCULT BLOOD TESTS (FOBT), BIOMARKER TESTS) and, by End User (Hospitals, CLINICAL DIAGNOSTIC LABORATORIES, PHYSICIANS’ OFFICE LABORATORIES, HOME TEST KIT): Global Opportunity Analysis and Industry Forecast, 2023-2032

• FECAL OCCULT BLOOD TESTS (FOBT)
• BIOMARKER TESTS

• Hospitals
• CLINICAL DIAGNOSTIC LABORATORIES
• PHYSICIANS’ OFFICE LABORATORIES
• HOME TEST KIT

• North America  (U.S., Canada, Mexico)
• Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
• Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
• LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)

Abbott Laboratories, Guardant Health, Inc., Epic Sciences, Inc., Roche Diagnostics, Cepheid Inc., Exact Sciences Corporation, Biocartis Group NV, Novartis AG, Quest Diagnostics Incorporated, Hologic, Inc.